Keng-Hao Chang
Papers
1
Total Citations
10
H-Index
1
About
Dr. Keng-Hao Chang is a leading cardiovascular surgeon whose research focuses on advancing minimally invasive coronary revascularization techniques, particularly robot-assisted coronary artery bypass grafting (R-CABG). His major contribution lies in systematically comparing the clinical outcomes of R-CABG against one-stage percutaneous coronary intervention (PCI) using drug-eluting stents for patients with multivessel coronary artery disease (MVD). His landmark 2019 study, cited 10 times, provided critical evidence on the safety and efficacy of robotic surgery as an alternative to traditional stenting, helping to refine treatment algorithms for complex MVD cases. By demonstrating that R-CABG can achieve comparable or superior outcomes to PCI, Dr. Chang has influenced clinical decision-making and expanded the role of robotic technology in cardiac surgery. His work bridges the gap between surgical innovation and evidence-based practice, offering patients less invasive options with potentially faster recovery. Dr. Chang’s research continues to shape the future of coronary artery disease management, making him a respected voice in the field of robotic cardiac surgery.
Research Focus
Key Achievements
Top Papers
- 1